NSC |
Compound |
Enrichment |
Correlation |
NSC 379399 |
Null |
0.0217366743178497 |
0.57959061 |
NSC 618262 |
Null |
0.0217366743178497 |
0.22515649 |
NSC 622398 |
Fascaplysine |
0.0217366743178497 |
0.18165526 |
NSC 623527 |
Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt |
0.0217366743178497 |
0.094327901 |
NSC 628114 |
9-N(N'-chloroethyl-N'-ethyl-1,2-diaminoethyl) 2-methoxyacridine dihydrochloride |
0.0217366743178497 |
0.18968354 |
NSC 633530 |
1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- |
0.0217366743178497 |
0.14887421 |
NSC 635000 |
Null |
0.0217366743178497 |
0.30816017 |
NSC 639512 |
Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0217366743178497 |
0.19774574 |
NSC 641233 |
2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- |
0.0217366743178497 |
0.43832763 |
NSC 641297 |
ANTINEOPLASTIC-641297 |
0.0217366743178497 |
0.029497651 |